ICON plc operates as a clinical research organization, which engages in the provision of outsourced development services to the pharmaceutical, biotechnology, and medical device industries. It specializes in the development, management and analysis of programs that support clinical development. It operates through the following geographical segments: Ireland, Rest of Europe, U.S. and Other. The company was founded by John Climax and Ronan Lambe in June 1990 and is headquartered in Dublin, Ireland.
Current Value
$212.761 Year Return
Current Value
$212.761 Year Return
Market Cap
$17.57B
P/E Ratio
23.69
1Y Stock Return
-21.76%
1Y Revenue Growth
3.63%
Dividend Yield
0.00%
Price to Book
1.8
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
IQV | 63.78% | $35.86B | -5.69% | 0.00% |
WEX | 52.09% | $7.23B | +4.70% | 0.00% |
STM | 49.48% | $21.92B | -45.80% | 1.23% |
FCN | 49.28% | $7.12B | -10.52% | 0.00% |
TER | 48.64% | $17.19B | +14.15% | 0.45% |
EEFT | 45.99% | $4.61B | +19.89% | 0.00% |
CRL | 45.44% | $9.93B | -0.39% | 0.00% |
NVT | 44.22% | $12.85B | +43.55% | 0.97% |
TMHC | 43.91% | $7.19B | +54.45% | 0.00% |
BAM | 43.63% | $23.27B | +63.56% | 2.61% |
TOL | 43.51% | $15.38B | +78.60% | 0.58% |
FLEX | 43.25% | $15.72B | +111.70% | 0.00% |
ESI | 43.23% | $6.92B | +39.25% | 1.12% |
HLNE | 43.21% | $8.28B | +110.84% | 0.93% |
MRNS | 42.72% | $17.79M | -94.70% | 0.00% |
MTSI | 42.50% | $9.51B | +55.97% | 0.00% |
MFA | 42.38% | $1.12B | +4.10% | 12.75% |
AMG | 42.22% | $5.64B | +40.08% | 0.02% |
MEDP | 42.02% | $10.62B | +23.46% | 0.00% |
PATK | 41.93% | $2.98B | +58.25% | 1.64% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
SMC | -0.22% | $383.35M | +91.49% | 0.00% |
CANG | 0.48% | $282.47M | +245.13% | 0.00% |
CAH | 0.55% | $29.87B | +16.57% | 1.63% |
LICY | -0.55% | $48.30M | -64.70% | 0.00% |
DXCM | -0.60% | $29.08B | -32.80% | 0.00% |
MCK | -0.64% | $79.75B | +37.34% | 0.41% |
CBRE | -0.65% | $40.29B | +67.79% | 0.00% |
KDP | 0.66% | $43.73B | -0.52% | 2.71% |
VMI | -0.66% | $6.79B | +61.11% | 0.71% |
NTZ | 0.74% | $47.64M | -30.80% | 0.00% |
MNOV | -0.75% | $98.09M | +5.26% | 0.00% |
JNPR | -0.84% | $11.73B | +31.03% | 2.48% |
IMKTA | -0.85% | $1.31B | -13.44% | 0.93% |
MGPI | -0.86% | $1.03B | -49.60% | 1.02% |
QDEL | 0.88% | $2.55B | -45.10% | 0.00% |
UNH | -0.96% | $549.86B | +9.88% | 1.34% |
WHLM | -0.97% | $19.81M | -14.82% | 0.00% |
SMP | -1.01% | $698.79M | -9.81% | 3.59% |
BTCT | -1.01% | $58.86M | +395.83% | 0.00% |
ADM | 1.08% | $25.43B | -28.44% | 3.78% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
MOH | -24.58% | $16.94B | -18.86% | 0.00% |
HUSA | -19.70% | $18.58M | -19.77% | 0.00% |
WH | -16.92% | $7.50B | +23.40% | 1.54% |
TMUS | -16.91% | $274.55B | +58.87% | 0.82% |
GSHD | -16.72% | $2.98B | +69.11% | 0.00% |
LMT | -16.25% | $128.48B | +20.34% | 2.32% |
TSLA | -15.46% | $1.09T | +45.02% | 0.00% |
PULM | -15.33% | $22.32M | +230.27% | 0.00% |
LTM | -15.20% | $8.37B | -100.00% | <0.01% |
AMSF | -14.14% | $1.11B | +21.09% | 2.48% |
NOC | -13.20% | $72.32B | +5.29% | 1.58% |
POAI | -13.02% | $4.59M | -76.64% | 0.00% |
MNR | -12.82% | $1.70B | -6.89% | 15.55% |
KHC | -12.58% | $37.59B | -10.35% | 5.13% |
GIS | -12.52% | $35.60B | -1.16% | 3.70% |
ADT | -12.16% | $6.84B | +26.94% | 2.64% |
ACIC | -12.00% | $642.09M | +62.64% | 0.00% |
MTLS | -9.89% | $441.82M | +16.69% | 0.00% |
TCTM | -9.66% | $7.57M | -41.30% | 0.00% |
CBOE | -8.47% | $22.09B | +17.17% | 1.08% |
Yahoo
Baron Funds, an investment management company, released its “Baron Small Cap Fund” third-quarter 2024 investor letter. A copy of the letter can be downloaded here. The fund returned 9.68% (Institutional Shares) in the quarter outperforming the Russell 2000 Growth Index’s 8.41% return and the broader Russell 3000 Index’s 6.23% return. For the first nine months […]
Yahoo
Baird analyst Eric Coldwell lowered the firm’s price target on Icon (ICLR) to $225 from $249 and keeps a Neutral rating on the shares. The firm is concerned about sector fundamental performance through the first half of 2025, at minimum, but says Icon’s current valuation “feels so oversold we are willing to make a near-term positive trading call.” Near-term volatility is expected for contract research organizations, while long-term secular drivers remain in place, the analyst tells investors in
Yahoo
We recently published a list of 12 High Growth Large Cap Stocks to Buy Now. In this article, we are going to take a look at where ICON Public Limited Company (NASDAQ:ICLR) stands against other high growth large cap stocks. BlackRock highlighted that its portfolio managers are broadly optimistic about US equities. Its portfolio managers opine […]
Finnhub
Glancy Prongay & Murray LLP , a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of ICON Public Limited Company investors concerning the...
Finnhub
Law Offices of Howard G. Smith announces an investigation on behalf of ICON Public Limited Company investors concerning the Company’s possible violations of federal securities laws.On October...
Finnhub
SAN DIEGO, Nov. 15, 2024 /PRNewswire/ -- Shareholder rights law firm Johnson Fistel, LLP is investigating whether ICON Public Limited Company , any of its executive officers or others violated...
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BTAL | -27.12% | $379.51M | 1.43% |
VIXY | -25.39% | $195.31M | 0.85% |
TAIL | -23.56% | $68.06M | 0.59% |
JUCY | -19.93% | $325.31M | 0.6% |
TPMN | -13.50% | $40.73M | 0.65% |
USDU | -12.23% | $201.83M | 0.5% |
SOYB | -8.16% | $27.32M | 0.22% |
CORN | -7.15% | $61.32M | 0.2% |
CTA | -6.88% | $359.48M | 0.78% |
UUP | -6.64% | $359.07M | 0.77% |
BILZ | -6.43% | $553.02M | 0.14% |
SPTS | -6.26% | $5.70B | 0.03% |
UNG | -5.98% | $928.64M | 1.06% |
KMLM | -5.46% | $348.59M | 0.9% |
EQLS | -5.41% | $8.88M | 1% |
JBBB | -3.17% | $1.27B | 0.49% |
CCOR | -2.91% | $108.59M | 1.18% |
IVOL | -2.23% | $549.88M | 1.02% |
HDRO | -2.07% | $164.26M | 0.3% |
DBO | -1.83% | $218.38M | 0.77% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
XBIL | -0.19% | $637.84M | 0.15% |
DBE | -0.41% | $50.92M | 0.77% |
ULST | 0.83% | $535.66M | 0.2% |
USCI | 0.89% | $185.92M | 1.07% |
GSG | 1.16% | $935.59M | 0.75% |
PDBC | 1.27% | $4.47B | 0.59% |
COMT | 1.38% | $842.63M | 0.48% |
WEAT | -1.38% | $123.26M | 0.28% |
CLOI | 1.66% | $720.91M | 0.4% |
DBO | -1.83% | $218.38M | 0.77% |
KCCA | 1.97% | $219.64M | 0.87% |
HDRO | -2.07% | $164.26M | 0.3% |
IVOL | -2.23% | $549.88M | 1.02% |
XHLF | 2.30% | $883.02M | 0.03% |
CCOR | -2.91% | $108.59M | 1.18% |
JBBB | -3.17% | $1.27B | 0.49% |
DBC | 3.64% | $1.41B | 0.87% |
FMF | 3.95% | $243.44M | 0.95% |
XONE | 3.96% | $550.61M | 0.03% |
BSCO | 4.21% | $2.31B | 0.1% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
FMDE | 54.07% | $2.04B | 0.23% |
QGRO | 53.25% | $1.17B | 0.29% |
XT | 53.24% | $3.41B | 0.46% |
VOT | 53.10% | $15.45B | 0.07% |
VXF | 53.05% | $21.85B | 0.06% |
BOTZ | 52.61% | $2.62B | 0.68% |
PFUT | 46.97% | $322.01M | 0.64% |
BBH | 46.88% | $404.59M | 0.35% |
BIBL | 45.91% | $346.45M | 0.35% |
QQQJ | 45.68% | $660.90M | 0.15% |
XMHQ | 45.10% | $6.10B | 0.25% |
CGDV | 44.49% | $11.85B | 0.33% |
IVOG | 44.48% | $1.14B | 0.15% |
MDYG | 44.48% | $2.83B | 0.15% |
DFVX | 44.44% | $322.14M | 0.22% |
CGGO | 44.35% | $4.64B | 0.47% |
VTI | 44.16% | $456.82B | 0.03% |
ITOT | 44.08% | $64.33B | 0.03% |
SCHK | 44.04% | $3.98B | 0.05% |
IWV | 44.01% | $15.52B | 0.2% |